[1] |
LU Renquan, LIU Guangyu, YANG Wentao, GUO Lin, GUAN Ming, SHAO Zhimin, XU Dazhi, NI Ming, TANG Feng, WANG Chaofu, LOU Jiatao, SUN Fenyong, XING Jinliang, PAN Yueyin.
Application consensus of peripheral blood HER2 gene amplification detection (digital PCR) in anti-HER2 therapy
[J]. China Oncology, 2022, 32(1): 90-96.
|
[2] |
MA Yifei , LIANG Xinjun , WEI Shaozhong .
Prognostic value of inflammatory and immune markers in resectable colorectal cancer
[J]. China Oncology, 2021, 31(9): 845-851.
|
[3] |
LEI Yajie , GAO Yi , WANG Zhijie , CHENG Xi , YANG Yufei , ZHOU Hongyu , CHEN Lihua , CHEN Yixin , LI Haoran , LI Ziting , WU Xiaohua .
Potential role of lymphadenectomy in patients with ovarian cancer (ⅠC-ⅡA): a retrospective trial
[J]. China Oncology, 2021, 31(8): 740-745.
|
[4] |
GAO Heli, XU Jin, YU Xianjun.
Advances in clinical diagnosis and treatment of gastroenteropancreatic neuroendocrine tumor G3
[J]. China Oncology, 2021, 31(7): 567-573.
|
[5] |
GONG Runze, HU Haiyan.
Clinical significance of CCL2 expression in osteosarcoma tissue
[J]. China Oncology, 2021, 31(6): 455-459.
|
[6] |
PENG Zishan, KONG Hui, BAO Zhen, ZHAO Hongxing, LIU Xin, LU Shaohua.
Clinicopathological analysis of 83 cases of multifocal lung adenocarcinoma
[J]. China Oncology, 2021, 31(5): 408-418.
|
[7] |
XIAO Feng , XIAO Jingwen , SHAO Jianguo , CHEN Liyan , GU Chunyan .
The expression of programmed death 1 in tumor-infiltrating lymphocytes of hepatocellular carcinoma and its correlation with prognosis
[J]. China Oncology, 2021, 31(5): 419-427.
|
[8] |
ZHU Jun, WU Xiaohua.
Leading research progress and prospect of gynecological oncology in 2020
[J]. China Oncology, 2021, 31(4): 250-256.
|
[9] |
WANG Chunjian , NIE Gang , MAO Yan .
The role of TRIP6 in breast cancer and its mechanism
[J]. China Oncology, 2021, 31(3): 161-169.
|
[10] |
WU Yuanyuan , WANG Jun , LIU Qinjiang , ZHANG Ming .
Analysis of prognostic factors and treatment strategies of anaplastic thyroid carcinoma
[J]. China Oncology, 2021, 31(3): 212-220.
|
[11] |
YANG Liusong , ZHU Yingfeng , TANG Jianmin .
Ten cases of epithelioid glioblastoma and review of literature
[J]. China Oncology, 2021, 31(2): 114-120.
|
[12] |
DING Ping’an , ZHANG Zhidong , YANG Peigang , LIN Yecheng , TIAN Yuan , XU Xiaosheng , WU Juan , LIU Ying , GUO Honghai , LIU Yang , WANG Dong , TAN Bibo , LI Yong , ZHAO Qun .
Clinicopathological characteristics and prognostic analysis of leptomeningeal metastasis from gastric cancer
[J]. China Oncology, 2021, 31(2): 126-135.
|
[13] |
ZHOU Hongyu , LI Haoran , CHENG Xi , CHEN Lihua , YANG Yufei , CHANG Bin .
Clinical characteristics of 11 patients with small cell carcinoma of the ovary, hypercalcemic type and literature review
[J]. China Oncology, 2021, 31(2): 136-142.
|
[14] |
LI Fei , SONG Yuan , LI Fang , ZHU Xiyang , HE Ming .
Treatment effect of thoracic surgery for Siewert type Ⅰ and type Ⅱ adenocarcinoma of the esophagogastric junction and prognostic study
[J]. China Oncology, 2021, 31(2): 143-150.
|
[15] |
GUO Ye , ZHANG Chenping .
Expert consensus on the treatment of recurrent/metastatic squamous cell carcinoma of the head and neck with anti-EGFR monoclonal antibody (2021 edition)
[J]. China Oncology, 2021, 31(12): 1220-1232.
|